Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with increased mortality and morbidity. 1 However, the etiology of most cases of AF remains unknown due to probable multifactorial mechanisms of pathogenesis. AF is likely influenced by the genetic background. [2] [3] [4] AF often occurs in association with hypertension, coronary heart disease, valvular heart disease, and heart failure. 5 In addition to regulating sodium balance and volume homeostasis, aldosterone, the principal mineralocorticoid hormone, also plays a major role in the cardiac fibrosis and remodeling. 6, 7 The aldosterone synthase (CYP11B2) gene (a 9-exon gene localized to chromosome 8q22) contains a common -344T>C polymorphism (a thymidine-tocytosine substitution) within its promoter region (rs1799998). 8 The C allele has been associated with increased binding to steroidogenic transcription factor 1 9 and with increased aldosterone synthase activity. 10, 11 However, the role of CYP11B2-344T>C polymorphsim in the development of AF has been investigated with conflicting results. Previous studies have suggested an association between the CYP11B2-344T>C polymorphism with an increased risk of AF. [12] [13] [14] However, other studies have failed to confirm such an association. 15, 16 The exact relationship between the CYP11B2-344T>C polymorphism and susceptibility to AF is not entirely established. Therefore, we performed a meta-analysis of all eligible studies to derive a more precise estimation of the association between the CYP11B2-344T>C polymorphism and AF.
Methods

Publication search and data extraction
The electronic databases PubMed, Embase, Web of Science, and CNKI (China National Knowledge Infrastructure) were searched for studies to include in the present meta-analysis, using the terms: ''aldosterone synthase,'' ''CYP11B2,'' ''genotype,'' ''-344T>C,'' ''atrial fibrillation,'' and ''polymorphism.'' An upper date limit of 31 March 2014 was used, but no earlier date limit was applied. Articles included in the meta-analysis were in any language, studied human subjects, were published in the primary literature and had no obvious overlap of subjects with other studies. We excluded studies with the same data or overlapping data by the same authors. Only published studies with full text articles were included. When more than one of the same patient population was included in several publications, only the most recent or complete study was used in this meta-analysis.
The following information was extracted from each study: first author, year of publication, ethnicity of study population, and the number of cases and controls for the -344T>C genotype. We did not define a minimum number of patients as a criterion for inclusion of a study in our meta-analysis. The studies included had to meet the following criteria: (a) evaluation of the CYP11B2 -344T>C polymorphism and AF risk; (b) case-control study (AF group vs control group).
Statistical analysis
The meta-analysis examined the overall association for the allele contrasts, the contrast of homozygotes, and the recessive and dominant models. The effect of the association was indicated as an odds ratio (OR) with its corresponding 95% confidence interval (CI). Pooled OR was estimated using fixed and random effects models. Heterogeneity between studies was tested using the Q statistic. Heterogeneity was considered statistically significant if p<0. 10 . Heterogeneity was quantified using the I 2 metric, which was independent of the number of studies in the meta-analysis (I 2 <25% no heterogeneity; I 2 = 25-50% moderate heterogeneity; and I 2 >50% large or extreme heterogeneity). Begg's funnel plot and Egger's test were performed to assess the publication bias in the literature. Hardy-Weinberg equilibrium (HWE) was checked in the control group of the eligible studies by the chi-square test. All calculations were performed using STATA 10.0.
Results
Study characteristics
We found 11 published articles addressing the relationship between CYP11B2-344T>C and AF. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] The studies were published between 2008-2014 (see Table 1 ). The Orenes-Pinero et al. study did not contain available genotype data in AF cases for estimating an OR and 95% CI. 22 This study was excluded from this meta-analysis. Ten studies were conducted in various populations of different ethnicities: eight studies were conducted in Chinese populations, one study was in an African American population, 21 and one study was in a Caucasian population. 17 Four studies were conducted in hypertension populations. 15, 16, 18, 19 In a study of the -344T>C polymorphism, 17 the distribution of genotypes in the control group was not in HWE (p<0.05), indicating genotyping errors and/or population stratification (Table 1 ). This study was excluded from this meta-analysis to clarify the effect of CYP11B2-344T>C on the risk of AF.
The studies provided 1629 cases and 2284 controls for -344T>C. For the whole case groups, the frequency of TT-homozygous individuals was 42.8%. However, 43.2% of TC-heterozygous individuals and 14.0% of CC-homozygous individuals displayed the -344T>C polymorphism. In whole control groups, the frequencies of TT-homozygous individuals, TC-heterozygous individuals, and CC-homozygous 
Meta-analysis results
All comparisons were listed in Table 2 . Overall, the C allele was significantly associated with a increased risk of AF compared with the T allele (OR=1.26; 95% CI=1.09-1.45). The contrast of homozygotes and the recessive model produced similar results. Moderate heterogeneity (I 2 =43%, p=0.08) was detected among the nine studies. To eliminate heterogeneity, we divided the nine studies into different source of controls and ethnic subgroups. Subsequently, heterogeneity disappeared in subgroups of hypertension subjects, which revealed that most of the studies could not be grouped. In the analysis stratified by hypertension subjects, the C allele was associated with an increased susceptibility risk of AF compared with the T allele (OR=1.18; 95% CI=1.04-1.33). No heterogeneity (I 2 =0%, p=1.0) was detected among the four studies. The contrast of homozygotes and the recessive model produced the same pattern of results as the allele contrast.
Publication bias
Begg's funnel plot and Egger's test were performed to assess the publication bias in the literature. Evaluation of publication bias for the 344C allele versus the T allele showed that the Egger test was not significant (p=0.323). These results do not indicate a potential for publication bias.
Discussion
Genetic susceptibility to AF has been the focus of research in the scientific community. Recently, genetic variants of the CYP11B2 gene have received attention in the etiology of AF. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] It has been demonstrated that the CYP11B2 gene is expressed in human cardiovascular tissue, so that high expression of the aldosterone synthase gene may cause a high tissue aldosterone concentration, which subsequently causes atrial fibrosis, conduction heterogeneity, and increases the substrate for the development of AF. The role of CYP11B2-344T>C polymorphsim in the development of AF has been investigated with conflicting results. The sample size, difference of cardiovascular disease, and ethnicity may explain the different result. This meta-analysis summarized all of the available data on the association between CYP11B2-344T>C and AF, including a total of 1629 cases and 2284 controls. Our results indicate evidence for an association between CYP11B2-344T>C and the risk of pathogenesis in AF. In the hypertension population, a significant association was found for the genetic models that were examined. In addition, heterogeneity disappeared when the population was viewed as separate groups, which suggested that the effect of the C allele on the risk of AF might be in association with hypertension. Genetic variation of the CYP11B2 gene has been demonstrated to affect the transcription of CYP11B2 in vitro, 9 can modulate the expression of the enzyme, 10 and has been linked to increased aldosterone production as well as increased serum aldosterone level. 24 Aldosterone plays a major role in the cardiac fibrosis and remodeling. 6, 7 In an effort to shed light on the impact of CYP11B2-344T>C on AF, the data were pooled from available published trials for meta-analysis. A previous meta-analysis displayed several errors. 23 Firstly, Hu et al. had updated their research in 2011, 12 so that 115 cases were included in our study. Secondly, some studies were not included in that analysis. Thirdly, the Amir et al. study was included in that analysis, 17 whose distributions of genotypes in the control groups were not in HWE. 22 (1.10-1.35)  1.26 (1.09-1.45 Heterogeneity is a potential problem when interpreting the results from any meta-analysis. Heterogeneity can result from study differences such as the selection of controls, age distribution, and lifestyle factors. There are major differences in the genetic background within the different populations that have been studied. Therefore, further investigation is required to assess further stratifications.
Considering the limitations of this meta-analysis, our results should be interpreted with caution. Firstly, our results are based on unadjusted estimates. A more precise analysis should be conducted using individual data, which would allow researchers to adjust covariates including age, ethnicity, and different cardiovascular disease. Secondly, other genes encoding ion channels, angiotensinogen and angiotensin-converting enzyme (ACE) may also modulate the risk of AF.
In conclusion, our pooled data suggest evidence for a major role of CYP11B2-344T>C in the pathogenesis of AF among hypertension populations.
